DiegoAMoritaMD
Neurology • Morrisville, NCEpilepsy, Child Neurology, Clinical Pharmacology
Senior Medical Director, Global Clinical Development
Dr. Morita is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4000 Paramount Parkway
Suite 200
Morrisville, NC 27560Phone+1 919-767-3137- Is this information wrong?
Summary
- Dr. Diego Morita is a drug developer with a background in neurology. He received his medical degree from University of Buenos Aires. He completed a residency in pediatrics and fellowships in neurometabolic disorders, child neurology, clinical neurophysiology/epilepsy, and clinical pharmacology. He practiced as a child neurologist and epileptologist for 14 years at Cincinnati Children's Hospital Medical Center. He is currently a Senior Medical Director in Global Clinical Development at UCB Biosciences, specializing in epilepsy, pediatrics and rare diseases.
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Clinical Neurophysiology, 2001 - 2002- Cincinnati Children’s Hospital Medical CenterFellowship, Epilepsy, 2001 - 2002
- Cincinnati Children's Hospital Medical CenterFellowship, Child Neurology, 1998 - 2001
Nicklaus Children's HospitalResidency, Pediatrics, 1997 - 1998
Maimonides Medical CenterInternship, Transitional Year, 1996 - 1997
University of Buenos AiresClass of 1992
Certifications & Licensure
OH State Medical License 2004 - 2024
Publications & Presentations
PubMed
- Pharmacokinetics and safety of brivaracetam in neonates with repeated electroencephalographic seizures: A multicenter, open-label, single-arm study.Ronit Pressler, Geraldine Boylan, Eugene Dempsey, Kerstin Alexandra Klotz, Walter Krauwinkel, Edgar Will, Diego Morita, Florin Floricel, Jan-Peer Elshoff, John van den...> ;Epilepsia Open. 2024 Apr 1
- 1 citationsEfficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design.Thomas Bast, Anne-Liv Schulz, Florin Floricel, Diego Morita, Jody M Cleveland, Jan-Peer Elshoff> ;Epilepsia Open. 2022 Dec 1
- 6 citationsPharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open-label trial.Mark Kristof Farkas, Harriet Kang, Andras Fogarasi, Ali Bozorg, Gareth D James, Walter Krauwinkel, Diego Morita, Edgar Will, Jan-Peer Elshoff> ;Epilepsia. 2022 Apr 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
